Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Impact of alemtuzumab treatment on the survival and function of human regulatory T cells in vitro.
Assessment of sphingosine-1-phosphate receptor expression and associated intracellular signaling cascades in primary cells of the human central nervous system.
Demyelination affects temporal aspects of perception: An optic neuritis study.
Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis.
UPDATE 1-Teva Pharmaceutical banks on thrice-weekly Copaxone
Poor sleep in patients with multiple sclerosis.
Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study.
[Plasmapheresis in central nervous system disorders].
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).
BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.
Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.
Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis.
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.
Increased PK11195 PET binding in the cortex of patients with MS correlates with disability.
Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patients.
Neuropathology of white matter disease in Leber's hereditary optic neuropathy.
The INCAT disability score: A critical analysis of its measurement properties.
Apitope Announces Positive Results from Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Generic interferon-beta
Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis.
2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation.
Activation of axonal Kv7 channels in human peripheral nerve by flupirtine but not placebo - therapeutic potential for peripheral neuropathies: results of a randomised controlled trial.
Centocor briefing document for Ustekinumab, submitted to FDA
CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease.

Pages